SSA
TAK icon

Schonfeld Strategic Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-115,250
Closed -$1.8M – 2656
2025
Q4 		$1.8M Buy
+115,250
New +$1.65M 0.01% 915
2025
Q2 		– Sell
-79,464
Closed -$1.18M – 2530
2025
Q1 		$1.18M Buy
79,464
+14,113
+22% +$198K 0.01% 1216
2024
Q4 		$865K Sell
65,351
-17,851
-21% -$245K 0.01% 1179
2024
Q3 		$1.18M Sell
83,202
-6,198
-7% -$87.9K 0.01% 1107
2024
Q2 		$1.16M Buy
+89,400
New +$1.18M 0.01% 1135
2023
Q4 		– Sell
-136,100
Closed -$2.11M – 2196
2023
Q3 		$2.11M Buy
+136,100
New +$2.11M 0.02% 814
2022
Q3 		– Sell
-52,700
Closed -$740K – 3155
2022
Q2 		$740K Buy
52,700
+29,100
+123% +$415K 0.01% 1158
2022
Q1 		$338K Sell
23,600
-9,600
-29% -$141K ﹤0.01% 1616
2021
Q4 		$452K Buy
+33,200
New +$466K ﹤0.01% 1315
2021
Q3 		– Sell
-173,500
Closed -$2.92M – 2458
2021
Q2 		$2.92M Buy
173,500
+122,800
+242% +$2.09M 0.03% 600
2021
Q1 		$926K Buy
+50,700
New +$912K 0.01% 931
2020
Q3 		– Sell
-188,764
Closed -$3.38M – 1645
2020
Q2 		$3.38M Buy
+188,764
New +$3.39M 0.09% 289
2019
Q3 		– Sell
-54,900
Closed -$971K – 1229
2019
Q2 		$971K Hold
54,900
– – 0.03% 449
2019
Q1 		$1.12M Buy
+54,900
New +$1.1M 0.04% 475

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Schonfeld Strategic Advisors's TAK Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 115,250 shares — an estimated $1.8M sold.

Schonfeld Strategic Advisors first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $3.38M in Q2 2020. 362 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 115,250 Takeda Pharmaceutical shares in Q1 2026, an estimated $1.8M.
  • Schonfeld Strategic Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
  • Schonfeld Strategic Advisors's Takeda Pharmaceutical position peaked at $3.38M in Q2 2020.
  • 362 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.